Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Calvin You Jia Chen, Min Sen Yew, John Arputhan Abisheganaden & Huiying Xu. (2022) Predictors of Influenza PCR Positivity in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 25-32.
Read now
Read now
Yijuan Chen, Weiling Gu, Ben He, Huijuan Gao, Pinjing Sun, Qing Li, Enfu Chen & Ziping Miao. (2022) Impact of a community-based health education intervention on awareness of influenza, pneumonia, and vaccination intention in chronic patients. Human Vaccines & Immunotherapeutics 18:1, pages 1-8.
Read now
Read now
Sofía Tejada, Alexandre M. Tejo, Yolanda Peña-López, Carlos G. Forero, Xavier Corbella & Jordi Rello. (2021) Neuraminidase inhibitors and single dose baloxavir are effective and safe in uncomplicated influenza: a meta-analysis of randomized controlled trials. Expert Review of Clinical Pharmacology 14:7, pages 901-918.
Read now
Read now
Asko Järvinen, Jaana Joutseno & Marlene Gyldmark. (2007) Cost effectiveness of oseltamivir for the treatment of influenza in adults, adolescents and children in Finland. Journal of Medical Economics 10:3, pages 199-214.
Read now
Read now
Patrick Mallia & Sebastian L Johnston. (2007) Influenza infection and COPD. International Journal of Chronic Obstructive Pulmonary Disease 2:1, pages 55-64.
Read now
Read now
Articles from other publishers (31)
Ryan Hanula, Émilie Bortolussi-Courval, Arielle Mendel, Brian J. Ward, Todd C. Lee & Emily G. McDonald. (2023) Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With Influenza. JAMA Internal Medicine.
Crossref
Crossref
Aglaia Katsiroumpa, Panayota Sourtzi, Daphne Kaitelidou, Olga Siskou, Olympia Konstantakopoulou & Petros Galanis. (2023) Predictors of Seasonal Influenza Vaccination Willingness among High-Risk Populations Three Years after the Onset of the COVID-19 Pandemic. Vaccines 11:2, pages 331.
Crossref
Crossref
Stephanie Chow Garbern, Pryanka Relan, Gerard M O’Reilly, Corey B Bills, Megan Schultz, Indi Trehan, Sean M Kivlehan & Torben K Becker. (2022) A systematic review of acute and emergency care interventions for adolescents and adults with severe acute respiratory infections including COVID-19 in low- and middle-income countries. Journal of Global Health 12.
Crossref
Crossref
Lei Xu, Lei Zhao, Jinjing Che, Qian Zhang, Ruiyuan Cao & Xingzhou Li. (2021) Identification of novel influenza polymerase PB2 inhibitors using virtual screening approach and molecular dynamics simulation analysis of active compounds. Bioorganic & Medicinal Chemistry 52, pages 116515.
Crossref
Crossref
Jen-Wei Liu, Shen-Hua Lin, Lin-Chien Wang, Hsiao-Yean Chiu & Jen-Ai Lee. (2021) Comparison of Antiviral Agents for Seasonal Influenza Outcomes in Healthy Adults and Children. JAMA Network Open 4:8, pages e2119151.
Crossref
Crossref
Sofía Tejada, Miia Jansson, Candela Solé-Lleonart & Jordi Rello. (2021) Neuraminidase inhibitors are effective and safe in reducing influenza complications: meta-analysis of randomized controlled trials.. European Journal of Internal Medicine 86, pages 54-65.
Crossref
Crossref
So‐Jung Shim, Mei Chan, Louisa Owens, Adam Jaffe, Bernadette Prentice & Nusrat Homaira. (2021) Rate of use and effectiveness of oseltamivir in the treatment of influenza illness in high‐risk populations: A systematic review and meta‐analysis. Health Science Reports 4:1.
Crossref
Crossref
Motokazu Kato, Yutaka Saisho, Hiroshi Tanaka & Takuma Bando. (2020) Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre‐existing chronic respiratory disease: Findings of a randomized, open‐label study. Influenza and Other Respiratory Viruses 15:1, pages 132-141.
Crossref
Crossref
J. Schwarze, P. Openshaw, A. Jha, S. R. Giacco, D. Firinu, O. Tsilochristou, G. Roberts, A. Selby, C. Akdis, I. Agache, A. Custovic, E. Heffler, G. Pinna, M. Khaitov, A. Nikonova, N. Papadopoulos, A. Akhlaq, U. Nurmatov, H. Renz, A. Sheikh & C. Skevaki. (2018)
Influenza burden, prevention, and treatment in asthma‐A scoping review by the
EAACI
Influenza in asthma task force
. Allergy 73:6, pages 1151-1181.
Crossref
Crossref
Gabriela Żaroffe, Jacek Leluk, Agata Żyźniewska & Rafał Filip. (2017) Drug generations that combat influenza A virus infection. Bio-Algorithms and Med-Systems 13:1, pages 1-11.
Crossref
Crossref
Khin Hnin, Chau Nguyen, Kristin V Carson-Chahhoud, David J Evans, Michael Greenstone & Brian J Smith. (2015) Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults. Cochrane Database of Systematic Reviews 2017:8.
Crossref
Crossref
M. H. Ebell, M. Call & J. Shinholser. (2012) Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials. Family Practice 30:2, pages 125-133.
Crossref
Crossref
Kay Wang, Matthew Shun‐Shin, Peter Gill, Rafael Perera & Anthony Harnden. (2012) Cochrane Review: Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Evidence-Based Child Health: A Cochrane Review Journal 7:5, pages 1719-1790.
Crossref
Crossref
Kay Wang, Matthew Shun-Shin, Peter Gill, Rafael Perera & Anthony Harnden. (2012) Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Kay Wang, Matthew Shun-Shin, Peter Gill, Rafael Perera & Anthony Harnden. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Miguel A. Hernán & Marc Lipsitch. (2011) Reply to Cochrane Neuraminidase Inhibitors Review Team. Clinical Infectious Diseases 53:12, pages 1303-1304.
Crossref
Crossref
Susan E. Coffin, Kateri Leckerman, Ron Keren, Matthew Hall, Russell Localio & Theoklis E. Zaoutis. (2011) Oseltamivir Shortens Hospital Stays of Critically Ill Children Hospitalized With Seasonal Influenza. Pediatric Infectious Disease Journal 30:11, pages 962-966.
Crossref
Crossref
James R. Smith, Craig R. Rayner, Barbara Donner, Martina Wollenhaupt, Klaus Klumpp & Regina Dutkowski. (2011) Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience. Advances in Therapy 28:11, pages 927-959.
Crossref
Crossref
Shigeru Kohno, Hiroshi Kida, Masashi Mizuguchi, Nobuo Hirotsu, Tadashi Ishida, Junichi Kadota & Jingoro Shimada. (2011) Intravenous Peramivir for Treatment of Influenza A and B Virus Infection in High-Risk Patients. Antimicrobial Agents and Chemotherapy 55:6, pages 2803-2812.
Crossref
Crossref
Tom Jefferson, Mark A Jones, Peter Doshi, Chris B Del Mar, Liz Dooley & Ruth Foxlee. (2011) Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
M. E. Falagas, P. K. Koletsi, E. K. Vouloumanou, P. I. Rafailidis, A. M. Kapaskelis & J. Rello. (2010) Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy 65:7, pages 1330-1346.
Crossref
Crossref
Julio A. Farias, Analía Fernández, Ezequiel Monteverde, Nilda Vidal, Pilar Arias, María J. Montes, Gabriela Rodríguez, Mariela Allasia, Maria E. Ratto, Roxana Jaén, Claudia Meregalli, Karina Fiquepron, Ana R. Calvo, Alejandro Siaba, Lidia Albano, Rossana Poterala, Pablo Neira & Andrés Esteban. (2010) Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina. Intensive Care Medicine 36:6, pages 1015-1022.
Crossref
Crossref
James R. Smith, Robert E. Ariano & Stephen Toovey. (2010) The use of antiviral agents for the management of severe influenza. Critical Care Medicine 38, pages e43-e51.
Crossref
Crossref
R. Dutkowski. (2010) Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. Journal of Antimicrobial Chemotherapy 65:Supplement 2, pages ii11-ii24.
Crossref
Crossref
Pedro A. Piedra, Kathy L. Schulman & William A. Blumentals. (2009) Effects of Oseltamivir on Influenza-Related Complications in Children With Chronic Medical Conditions. Pediatrics 124:1, pages 170-178.
Crossref
Crossref
Sandra E. Talbird, Anita J. Brogan, Aleksander P. Winiarski & Beate Sander. (2009) Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States. American Journal of Health-System Pharmacy 66:5, pages 469-480.
Crossref
Crossref
Jerome J. Schentag, George Hill, Tom Chu & Craig R. Rayner. (2007) Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects. The Journal of Clinical Pharmacology 47:6, pages 689-696.
Crossref
Crossref
Nelson Lee, Paul KS Chan, Kin Wing Choi, Grace Lui, Bonnie Wong, Clive S Cockram, David SC Hui, Raymond Lai, Julian W Tang & Joseph JY Sung. (2007) Factors Associated with Early Hospital Discharge of Adult Influenza Patients. Antiviral Therapy 12:4, pages 501-508.
Crossref
Crossref
Fred Y Aoki, Guy Boivin & Noel Roberts. (2005) Influenza Virus Susceptibility and Resistance to Oseltamivir. Antiviral Therapy 12:4_part_2, pages 603-616.
Crossref
Crossref
T Jefferson, M Rudin, S Brodney Folse & F Davidoff. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Robert Bettis, Dominick Iacuzio, Thomas Jung, Rudolf Fuchs, Rick Aultman & Marlene Gyldmark. (2006) Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents. Clinical Drug Investigation 26:6, pages 329-340.
Crossref
Crossref